United Kingdom Cell and Gene Therapy Manufacturing QC Market Overview 2025-2028

Table Of Content

1. Executive Summary
   1. United Kingdom Cell and Gene Therapy Manufacturing QC Market Definition
   2. United Kingdom Cell and Gene Therapy Manufacturing QC Market Snapshot
   3. Key Investment Opportunities
   4. Key Success Tactics
   5. Key Influencing Elements
2. Research Scope & Segmentation
   1. Research Objectives
   2. Limitations & Assumptions
   3. United Kingdom Cell and Gene Therapy Manufacturing QC Market Scope & Segmentation
   4. Currency & Pricing Considered
3. United Kingdom Cell and Gene Therapy Manufacturing QC Market Opportunity Assessment
   1. Emerging Regions / Countries
   2. Emerging Companies
   3. Emerging Applications / End Use
4. United Kingdom Cell and Gene Therapy Manufacturing QC Market Dynamics
   1. United Kingdom Cell and Gene Therapy Manufacturing QC Market Drivers
   2. United Kingdom Cell and Gene Therapy Manufacturing QC Market Warning Factors
   3. Latest Macro Economic Indicators
   4. Geopolitical Impact
   5. Technology Factors
5. United Kingdom Cell and Gene Therapy Manufacturing QC Market Assessment
   1. Porter's Five Forces Analysis
   2. Value Chain Analysis
   3. PESTLE Analysis
6. United Kingdom Cell and Gene Therapy Manufacturing QC Market Segmentation
   
   1. United Kingdom Cell and Gene Therapy Manufacturing QC Market By Therapy Type (2021-2028)
      1. Cell Therapy
      2. Gene Therapy
   2. United Kingdom Cell and Gene Therapy Manufacturing QC Market By Cell Therapy (2021-2028)
      1. CAR-T
      2. CAR-NK
      3. B-Cell
      4. Other
   3. United Kingdom Cell and Gene Therapy Manufacturing QC Market By CAR-T (2021-2028)
      1. Autologous CAR-T
      2. Allogeneic CAR-T
   4. United Kingdom Cell and Gene Therapy Manufacturing QC Market By Gene Therapy (2021-2028)
      1. Viral
      2. Non-Viral
   5. United Kingdom Cell and Gene Therapy Manufacturing QC Market By Viral (2021-2028)
      1. AAV
      2. Lentiviral vectors
      3. Other
   6. United Kingdom Cell and Gene Therapy Manufacturing QC Market By Scale (2021-2028)
      1. Pre commercial/ R&D Manufacturing
      2. Commercial Scale Manufacturing
   7. United Kingdom Cell and Gene Therapy Manufacturing QC Market By Mode (2021-2028)
      1. Contract Manufacturing
      2. In-house Manufacturing
   8. United Kingdom Cell and Gene Therapy Manufacturing QC Market By Workflow (2021-2028)
      1. Cell Processing
      2. Cell Banking
      3. Fill & Finish Operations
      4. Raw Material Testing
      5. Vector Production
      6. Other Workflows
   9. United Kingdom Cell and Gene Therapy Manufacturing QC Market By Process (2021-2028)
      1. Upstream Processes
      2. Downstream Processes
   10. United Kingdom Cell and Gene Therapy Manufacturing QC Market By End User (2021-2028)
       1. Pharmaceutical Companies
       2. Biopharmaceutical / Biotechnological Companies
       3. Contract Manufacturing Organizations
   11. United Kingdom Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies (2021-2028)
       1. Small Size
       2. Medium Size
       3. Large Size
   12. United Kingdom Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies (2021-2028)
       1. Small Size
       2. Medium Size
       3. Large Size
   13. United Kingdom Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations (2021-2028)
       1. Small Size
       2. Medium Size
       3. Large Size
   14. United Kingdom Cell and Gene Therapy Manufacturing QC Market By Technology Type (2021-2028)
       1. Fluorescence-Activated Cell Sorting (FACS)
       2. Enzyme-Linked Immunosorbent Assay (ELISA)
       3. Chromatography
       4. Next-Generation Sequencing (NGS)
       5. Polymerase Chain Reaction (PCR)
       6. Others 
7. Competitive Landscape
   1. United Kingdom Cell and Gene Therapy Manufacturing QC Market Share By Players
   2. M&A Agreements & Collaboration Analysis
8. Company Profiles
9. Research Methodology